Product overview
A synthetic peptide studied in laboratory models of melanocortin receptor signaling. Supplied for controlled receptor-binding and pathway research.

$55.00
A synthetic peptide studied in laboratory models of melanocortin receptor signaling. Supplied for controlled receptor-binding and pathway research.
Select vial size
Quantity
Research background
PT-141, also known as bremelanotide, is a melanocortin receptor agonist that has been extensively investigated for effects involving melanocortin signaling and sexual-function pathways.
Unlike many compounds in the research-peptide space, bremelanotide has an FDA-approved prescription formulation for a specific medical indication. That approval does not mean an unapproved research formulation is equivalent to the approved pharmaceutical product. Research continues to investigate melanocortin receptor activity and its physiological effects.
Research disclaimer
All products are supplied strictly for in-vitro laboratory research, analytical research, or other legitimate scientific research purposes where applicable. Products are not intended for human or veterinary consumption, diagnosis, treatment, prevention, or mitigation of disease. Information presented on this website describes areas investigated in scientific literature and does not constitute medical advice or a claim that any product is safe or effective for a particular use. Research findings may include in-vitro, animal, observational, or limited human studies and should not be interpreted as equivalent to established clinical evidence. Many compounds in the research-peptide field lack sufficient human safety and efficacy data.
A synthetic peptide studied in laboratory models of melanocortin receptor signaling. Supplied for controlled receptor-binding and pathway research.
Information is presented for laboratory and analytical context only. Researchers should consult primary scientific literature and applicable institutional protocols.
Quantity: To be announced. Appearance, formula, molecular weight, and storage conditions will be published only when verified product documentation is available.
Lot number, test date, identity, purity, testing laboratory, and COA fields remain intentionally unpopulated until genuine Valora batch documentation is connected.